AYTU BIOPHARMA, INC Increase (Decrease) in Deferred Revenue
AYTU BIOPHARMA, INC (AYTU) reported Increase (Decrease) in Deferred Revenue of -$3.99 thousand for the 6-month period ending 2019-12-31, per its 10-Q filed 2020-02-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-02-14
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for the quarter ending 2019-12-31 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for the quarter ending 2019-09-30 was -$3.99K.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for the quarter ending 2019-06-30 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for the quarter ending 2019-03-31 was $0.00.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for fiscal 2019 was -$1.45K.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for fiscal 2018 was -$6.67K.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for fiscal 2017 was -$4.20K.
- AYTU BIOPHARMA, INC increase (decrease) in deferred revenue for fiscal 2016 was -$511.61K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$3.99K 10-Q · filed 2020-02-14 | -$3.99K derived: sum of 3 quarters · filed 2020-02-14 | -$3.99K derived: sum of 4 quarters · filed 2020-02-14 | |
| 2019-09-30 | -$3.99K 10-Q · filed 2019-11-14 | -$3.99K derived: sum of 2 quarters · filed 2019-11-14 | -$3.99K derived: sum of 3 quarters · filed 2019-11-14 | -$3.99K derived: sum of 4 quarters · filed 2020-02-14 | |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | $0.00 derived: sum of 2 quarters · filed 2019-09-26 | $0.00 derived: sum of 3 quarters · filed 2020-02-14 | -$1.45K 10-K · filed 2019-09-26 | |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-02-14 | -$1.45K 10-Q · filed 2019-05-14 | -$3.12K derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-14 | -$1.45K 10-Q · filed 2020-02-14 | -$3.12K derived: sum of 3 quarters · filed 2020-02-14 | -$4.79K derived: sum of 4 quarters · filed 2020-02-14 | |
| 2018-09-30 | -$1.45K 10-Q · filed 2019-11-14 | -$3.12K derived: sum of 2 quarters · filed 2019-11-14 | -$4.79K derived: sum of 3 quarters · filed 2019-11-14 | -$6.46K derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$1.67K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-26 | -$3.34K derived: sum of 2 quarters · filed 2019-09-26 | -$5.00K derived: sum of 3 quarters · filed 2019-09-26 | -$6.67K 10-K · filed 2019-09-26 | |
| 2018-03-31 | -$1.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | -$3.34K derived: sum of 2 quarters · filed 2019-05-14 | -$5.00K 10-Q · filed 2019-05-14 | -$9.21K derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$1.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-14 | -$3.34K 10-Q · filed 2019-05-14 | -$7.54K derived: sum of 3 quarters · filed 2019-05-14 | -$7.54K derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-09-30 | -$1.67K 10-Q · filed 2018-11-07 | -$5.87K derived: sum of 2 quarters · filed 2018-11-07 | -$5.87K derived: sum of 3 quarters · filed 2018-11-07 | -$5.87K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | -$4.20K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-06 | -$4.20K derived: sum of 2 quarters · filed 2018-09-06 | -$4.20K derived: sum of 3 quarters · filed 2018-09-06 | -$4.20K 10-K · filed 2018-09-06 | $0.00 10-K · filed 2017-08-31 |
| 2017-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $0.00 derived: sum of 2 quarters · filed 2017-05-11 | $0.00 10-Q · filed 2017-05-11 | -$447.32K derived: sum of 4 quarters · filed 2017-08-31 | |
| 2016-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | $0.00 10-Q · filed 2017-02-09 | -$447.32K derived: sum of 3 quarters · filed 2017-08-31 | -$468.75K derived: sum of 4 quarters · filed 2017-08-31 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-07 | -$447.32K derived: sum of 2 quarters · filed 2017-08-31 | -$468.75K derived: sum of 3 quarters · filed 2017-08-31 | -$490.18K derived: sum of 4 quarters · filed 2017-08-31 | |
| 2016-06-30 | -$447.32K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | -$468.75K derived: sum of 2 quarters · filed 2017-08-31 | -$490.18K derived: sum of 3 quarters · filed 2017-08-31 | -$511.61K 10-K · filed 2017-08-31 | |
| 2016-03-31 | -$21.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | -$42.86K derived: sum of 2 quarters · filed 2017-05-11 | -$64.29K 10-Q · filed 2017-05-11 | -$85.71K derived: sum of 4 quarters · filed 2017-05-11 | |
| 2015-12-31 | -$21.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$42.86K 10-Q · filed 2017-02-09 | -$64.28K derived: sum of 3 quarters · filed 2017-02-09 | -$85.71K derived: sum of 4 quarters · filed 2017-02-09 | |
| 2015-09-30 | -$21.43K 10-Q · filed 2016-11-07 | -$42.86K derived: sum of 2 quarters · filed 2016-11-07 | -$64.28K derived: sum of 3 quarters · filed 2016-11-07 | -$85.71K derived: sum of 4 quarters · filed 2016-11-07 | |
| 2015-06-30 | -$21.43K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | -$42.86K derived: sum of 2 quarters · filed 2016-09-01 | -$64.28K derived: sum of 3 quarters · filed 2016-09-01 | -$85.71K 10-K · filed 2016-09-01 | |
| 2015-03-31 | -$21.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | -$42.86K derived: sum of 2 quarters · filed 2016-05-11 | -$64.29K 10-Q · filed 2016-05-11 | $164.28K derived: sum of 4 quarters · filed 2016-05-11 | |
| 2014-12-31 | -$21.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-11 | -$42.86K 10-Q · filed 2016-02-11 | $185.71K derived: sum of 3 quarters · filed 2016-02-11 | ||
| 2014-09-30 | -$21.43K 10-Q · filed 2015-11-06 | $207.14K derived: sum of 2 quarters · filed 2015-11-06 | |||
| 2014-06-30 | $228.57K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-28 | $191.07K 10-K · filed 2015-09-28 | |||
| 2014-03-31 | -$37.50K 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |